Longqian Capital is an investment firm that provides asset management, investment management and consulting services.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Sep 14, 2022
Worg Pharmaceuticals
|
Series B | ¥400M | Biotechnology | — |
Apr 1, 2022
Ke Ning Bio
|
Seed | ¥100M | Biotechnology | Yes |
Mar 30, 2022
Chinagene Tech
|
Series A | ¥100M | Clinical Trials | Yes |
Mar 9, 2022
Toll PATEO
|
Series A | ¥100M | Biotechnology | Yes |
Jan 9, 2018
huaxuejia.cn
|
Seed | ¥3M | Biotechnology | — |